🇺🇸 FDA
Pipeline program

anti-CD133-CAR vector-transduced T cells

s2015-080-03

Phase 2 mab completed

Quick answer

anti-CD133-CAR vector-transduced T cells for Liver Cancer is a Phase 2 program (mab) at Chinese PLA General Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
Chinese PLA General Hospital
Indication
Liver Cancer
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials